These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 7564363)

  • 1. Renal and systemic effects of the renin inhibitor remikiren in patients with essential hypertension.
    van Paassen P; de Zeeuw D; de Jong PE
    J Cardiovasc Pharmacol; 1995 Jul; 26(1):39-45. PubMed ID: 7564363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal and systemic effects of continued treatment with renin inhibitor remikiren in hypertensive patients with normal and impaired renal function.
    van Paassen P; de Zeeuw D; Navis G; de Jong PE
    Nephrol Dial Transplant; 2000 May; 15(5):637-43. PubMed ID: 10809804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pretreatment renal vascular tone predicts the effect of specific renin inhibition on natriuresis in essential hypertension.
    van Paassen P; Navis GJ; De Jong PE; De Zeeuw D
    Eur J Clin Invest; 1999 Dec; 29(12):1019-26. PubMed ID: 10583449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does the renin-angiotensin system determine the renal and systemic hemodynamic response to sodium in patients with essential hypertension?
    van Paassen P; de Zeeuw D; Navis G; de Jong PE
    Hypertension; 1996 Feb; 27(2):202-8. PubMed ID: 8567042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Remikiren (Ro 42-5892)--an orally active renin inhibitor in essential hypertension. Effects on blood pressure and the renin-angiotensin-aldosterone system.
    Himmelmann A; Bergbrant A; Svensson A; Hansson L; Aurell M
    Am J Hypertens; 1996 Jun; 9(6):517-22. PubMed ID: 8783774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renin inhibition improves pressure natriuresis in essential hypertension.
    Paassen PV; Zeeuw D; Jong PE; Navis G
    J Am Soc Nephrol; 2000 Oct; 11(10):1813-1818. PubMed ID: 11004211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of Direct Renin Blockade on Renal & Systemic Hemodynamics and on RAAS Activity, in Weight Excess and Hypertension: A Randomized Clinical Trial.
    Kwakernaak AJ; Roksnoer LC; Lambers Heerspink HJ; van den Berg-Garrelds I; Lochorn GA; van Embden Andres JH; Klijn MA; Kobori H; Danser AH; Laverman GD; Navis GJ
    PLoS One; 2017; 12(1):e0169258. PubMed ID: 28118402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal and hormonal responses to direct renin inhibition with aliskiren in healthy humans.
    Fisher ND; Jan Danser AH; Nussberger J; Dole WP; Hollenberg NK
    Circulation; 2008 Jun; 117(25):3199-205. PubMed ID: 18559696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of the role of the renin-angiotensin system in cardiac contractility utilizing the renin inhibitor remikiren.
    van Kats JP; Sassen LM; Danser AH; Polak MP; Soei LK; Derkx FH; Schalekamp MA; Verdouw PD
    Br J Pharmacol; 1996 Mar; 117(5):891-901. PubMed ID: 8851507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple dose pharmacokinetics and concentration effect relationship of the orally active renin inhibitor remikiren (Ro 42-5892) in hypertensive patients.
    Weber C; Birnböck H; Leube J; Kobrin I; Kleinbloesem CH; Van Brummelen P
    Br J Clin Pharmacol; 1993 Dec; 36(6):547-54. PubMed ID: 12959271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natriuretic effect and changes in renal haemodynamics induced by enalapril in essential hypertension.
    Sánchez RA; Marcó E; Gilbert HB; Raffaele P; Brito M; Giménez M; Moledo LI
    Drugs; 1985; 30 Suppl 1():49-58. PubMed ID: 2994987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of inhibition of converting enzyme on renal hemodynamics and sodium management in polycystic kidney disease.
    Torres VE; Wilson DM; Burnett JC; Johnson CM; Offord KP
    Mayo Clin Proc; 1991 Oct; 66(10):1010-7. PubMed ID: 1921483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Angiotensin-converting enzyme inhibition: direct and indirect mechanisms].
    Stumpe KO
    Klin Wochenschr; 1985 Sep; 63(18):897-906. PubMed ID: 2997540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of subpressor doses of angiotensin II on renal hemodynamics in relation to blood pressure.
    Ljungman S; Aurell M; Hartford M; Wikstrand J; Berglund G
    Hypertension; 1983; 5(3):368-74. PubMed ID: 6341220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of converting enzyme inhibition on the enhanced proximal sodium reabsorption induced by chronic diuretic treatment in patients with essential hypertension.
    van Schaik BA; Geyskes GG; Dorhout Mees EJ
    Nephron; 1987; 47(3):167-72. PubMed ID: 2825050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of remikiren as the first orally active renin inhibitor.
    Clozel JP; Fischli W
    Arzneimittelforschung; 1993 Feb; 43(2A):260-2. PubMed ID: 8498974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic and renal hemodynamic effects of celiprolol in essential hypertensives.
    Lucarini AR; Salvetti A
    Am J Cardiol; 1988 Feb; 61(5):45C-48C. PubMed ID: 2963525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of antihypertensive, renal hemodynamic, and humoral effects of pinacidil and hydralazine monotherapy.
    Abraham PA; Halstenson CE; Matzke GR; Keane WF
    J Clin Hypertens; 1987 Dec; 3(4):439-51. PubMed ID: 3330986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal hemodynamics and sodium excretion after acute and chronic administration of cicletanine in normotensive and hypertensive subjects.
    Moulin B; Fillastre JP; Godin M; Coquerel A; Decoopman E
    J Cardiovasc Pharmacol; 1995 Feb; 25(2):292-9. PubMed ID: 7752655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemodynamics, biochemical effects, and pharmacokinetics of the renin inhibitor remikiren in healthy human subjects.
    Kleinbloesem CH; Weber C; Fahrner E; Dellenbach M; Welker H; Schröter V; Belz GG
    Clin Pharmacol Ther; 1993 May; 53(5):585-92. PubMed ID: 8491068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.